$RTX

RTX's Pratt & Whitney unit will invest $25 million to expand a Polish plant producing F135 engine parts for F-35 variants, creating 120 jobs. The facility also supplies parts for commercial aircraft engines. The investment is part of a $125 million commitment to Polish operations this year, aiming to meet global demand for advanced aircraft engines.

Bloomberg Intelligence analyst Wayne Sanders noted that laser weapons' size has shrunk, but they rely on minerals China has restricted. RTX (Raytheon) reported Q2 revenue of $8.27B, up 18%, with a $289B backlog. CEO Chris Calio highlighted supply chain risks. Lockheed Martin (LMT) and Boeing (BA) also mentioned rare-earth mineral risks. RTX is up 30% over a year, while MP Materials, a rare-earth supplier, is down 19%.

RTX Corp (NYSE: RTX) announced a $25 million investment to expand its manufacturing facility in Poland, boosting production capacity for aircraft engine components. The company's stock is trading at $202.13, 31.2% above its GF Value™ of $154.02, indicating overvaluation. RTX has a GF Score™ of 84, reflecting strong financial health and growth. Insiders have sold $41.8 million in shares over the past year, with no reported purchases.

RTX's Pratt & Whitney is investing $25 million to expand its manufacturing facility in Niepołomice, Poland, adding 120 jobs and increasing production capacity for commercial and military engine components, with operations expected to start in 2028.

Parsons (PSN) reported flat Q2 revenue of $1.58B, missing estimates, and lowered full-year guidance, causing its stock to drop 26.3%. BWX (BWXT) reported $901.6M revenue, up 18%, meeting expectations and beating EBITDA guidance. RTX (RTX) reported $24.71B revenue, up 14.5%, beating expectations and raising EPS guidance. The stock is up 3.2% since reporting.

RTX Corporation has a 'Moderate Buy' rating from 25 analysts, with a mean price target of $232.38, implying 11.9% upside. Northrop Grumman (NOC) has underperformed, down 4.8% YTD and 8% over 52 weeks.

RTX (NYSE: RTX) reported Q2 revenue of $24.7B, up 14% YoY, and adjusted EPS of $1.89, up 21%. Its backlog grew 22% to $289B, with 60% from commercial aerospace and 40% from defense. Recent $22.9B Tomahawk missile contract adds to backlog. RTX expects $95B-$96B in sales for 2024.

RTX is favored over GE in a relative-value setup due to lower valuation, higher cash yield, and better momentum. RTX trades at $204.80 with a 4.1% FCF yield and 28.3x forward P/E, while GE trades at $330.64 with 2.4% FCF yield and 42.2x forward P/E. Both stocks face short-term technical pressure, with RTX showing relative strength.

Lockheed Martin, Raytheon (RTX), and Tata Advanced Systems Limited signed an agreement to co-produce Javelin missiles in India. The deal aims to boost India's defense manufacturing and U.S.-India defense partnership, with production supporting U.S. jobs and Indian workforce development, according to Lockheed Martin.

Amazon faces an FTC lawsuit over ad revenue. Tesla reports mixed European car registrations. Apple's Tim Cook to step down as CEO. Eli Lilly reports positive drug trial results. Multiple companies, including Exxon, RTX, and Medtronic, announce strategic moves and financial updates. Various European and global firms report earnings, trials, and operational changes.